FR 
EN 
Clinical Trial Insights
Welcome to Cytel’s Insights hub—your go-to destination for the latest news, event updates, and expert insights on advanced analytical methods and data science. Come on in!
Revolutionizing Breast Cancer Care
Discover our latest groundbreaking breast cancer research: “Omitting Axillary Dissection in Breast Cancer,” published in NEJM. This collaborative effort with the SENOMAC Trialists’ Group pioneers a new treatment approach that reduces side effects while maintaining efficacy. With its significant impact on treatment protocols and patient outcomes, the new approach has the potential to transform the future of breast cancer care.
Read morePerspectives
Our experts share cutting-edge insights, industry trends, and in-depth analyses spanning the full spectrum of drug lifecycle management, from initial development through to successful commercialization.
News and Events
Stay up to date with the latest news and events here at Cytel and beyond. We will inform you about the upcoming industry events, our participation and contribution, keeping you connected and in the know.
<trp-post-container data-trp-post-id='3919'>Webinar – Cytel Fit for Purpose (FFP) Real World Data Tool</trp-post-container>
<trp-post-container data-trp-post-id='3599'>Webinar – Oncology Trials: External Control Arms and Bayesian Borrowing</trp-post-container>
<trp-post-container data-trp-post-id='3602'>Webinar Series: EU JCA Preparation and HTA Regulation</trp-post-container>
Resource Library
The Cytel Library is always open—explore our extensive collection of articles, white papers, case studies, and more to discover how we are shaping the future of drug development.
<trp-post-container data-trp-post-id='3601'>White Paper – Adaptive Design Solutions for Rare Diseases Study Challenges</trp-post-container>
<trp-post-container data-trp-post-id='3616'>Future Trials for Combination Cancer Therapy</trp-post-container>
<trp-post-container data-trp-post-id='3788'>The Good Data Doctor on Data Submission and Data Integration</trp-post-container>
Publications
Stay up to date with our latest peer-reviewed publications on our Cytel pubmed page.
<trp-post-container data-trp-post-id='4301'>Augmenting external control arms using Bayesian borrowing: a case study in first-line non-small cell lung cancer. Struebing A, McKibbon C, Ruan H, Mackay E, Dennis N, Velummailum R, He P, Tanaka Y, Xiong Y, Springford A, Rosenlund M., J Comp Eff Res. 2024</trp-post-container>
<trp-post-container data-trp-post-id='4314'>Clinical outcomes for previously treated patients with advanced biliary tract cancer: a meta-analysis. Amonkar MM, Abderhalden LA, Fox GE, Frederickson AM, Grira T, Gozman A, Malhotra U, Malbecq W, Akers KG., Future Oncol. 2024</trp-post-container>
<trp-post-container data-trp-post-id='4327'>Justifying the source of external comparators in single-arm oncology health technology submissions: a review of NICE and PBAC assessments. Appiah K, Rizzo M, Sarri G, Hernandez L., J Comp Eff Res. 2024</trp-post-container>
<trp-post-container data-trp-post-id='4309'>Epidemiology and Real-World Treatment of Incident Diffuse Large B-cell Lymphoma (DLBCL): A German Claims Data Analysis. Pacis S, Bolzani A, Heuck A, Gossens K, Kruse M, Fritz B, Maywald U, Wilke T, Kunz C., Oncol Ther. 2024</trp-post-container>
Cytel Design Institute
Visit the Cytel Design Institute to uncover the workings of our advanced clinical trial design. We share 35+ years of pioneering expertise, from innovative study design to powerful real-world evidence applications.
Learn more about the Cytel Design InstituteClaim your free 30-minute strategy session
Book a free, no-obligation strategy session with a Cytel expert to get advice on how to improve your drug’s probability of success and plot a clearer route to market.
